RNTX Rein Therapeutics, Inc.
$0.79▲ +0.53%
Healthcare
Other
After hours
$0.81▲ +3.69%
Sep 11, 5:30 PM ET
Volume 270.6K
Avg Volume (10D) 459.4K
Key Metrics & Fundamentals
Market Cap
$67.72M
P/E Ratio
–
Div Yield
–%
52W Range
0.69 - 2.18
% vs 50 MA
-5.51%
% vs 200 MA
-31.54%
RSI-14
46.3
MACD Histogram
+0.0000
Beta (1Y vs SPY)
1.74
Free Cash Flow
-$8.64M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$6.08M
COGS
–
Operating Exp
$6.08M
Operating Income
-$6.08M
EBIT
-$6.08M
Pretax Income
-$6.38M
Net Income
-$6.38M
EPS (Diluted)
-0.10
Price & Volume History
Loading chart…
Recent News
Rein Therapeutics to Present Late-Breaking Poster at the European Respiratory Society (ERS) 2026 Congress
GlobeNewswire · Sep 4, 2026 12:00 PM
Rein Therapeutics to Present at Upcoming September Investor Conferences
GlobeNewswire · Sep 3, 2026 8:01 PM
Here's Why You Should Add RNTX Stock to Your Portfolio Now
Zacks · Sep 3, 2026 3:01 PM
Rein Therapeutics Receives U.S. FDA Fast Track Designation for LTI-03 in Idiopathic Pulmonary Fibrosis
GlobeNewswire · Aug 20, 2026 12:00 PM
Rein Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
GlobeNewswire · Aug 14, 2026 10:44 AM
Rein Therapeutics Announces Publication of Landmark LTI-03 Clinical Data in Nature Communications
GlobeNewswire · Aug 4, 2026 12:00 PM
Rein Therapeutics Completes Global Expansion of Phase 2 IPF Trial
MT Newswires · Jul 21, 2026 12:24 PM
Rein Therapeutics Announces Phase 2 RENEW Trial Now Enrolling Across All Five Countries
GlobeNewswire · Jul 21, 2026 12:00 PM
All You Need to Know About Rein Therapeutics Inc. (RNTX) Rating Upgrade to Buy
Zacks · Jun 17, 2026 4:00 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See RNTX's money flow as a full page
Social Sentiment
No Reddit posts found for RNTX.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.